Mood Disorders With HIV Increase Risk for Noncommunicable Disease
Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
HIV/AIDS Information Center
HIV Infection Linked to Early Menopause
Researchers studied the average age of menopause, prevalence of early menopause and premature menopause, and correlates of menopause occurring at <45 years in women living with HIV.
HIV Therapy Symtuza Approved for Use in Pediatric Patients
Symtuza is a 4-drug combination of darunavir, an HIV-1 protease inhibitor; cobicistat, a CYP3A inhibitor; and emtricitabine and tenofovir alafenamide.
Few Adolescent Men Who Have Sex With Men Have Had HIV Test
Most have regular doctor, but few have had conversations about same-sex sexual behaviors, HIV testing.
HIV Vaccine Ineffective, Clinical Trial Halted
NIH-sponsored trial was being conducted in South Africa.
Update on Adverse Reactions of HIV Integrase Inhibitors
Integrase strand transfer inhibitors (INSTIs) are a generally well-tolerated class of antiretrovirals that have a higher antiviral potency compared with other classes of ART.
Initiating Conversations About HIV Prevention
Effective implementation of HIV prevention strategies begins with appropriate patient-clinician communication, and one of the most important things a nurse practitioner and physician assistant can do is normalize the conversation.
CDC: HIV-1/HIV-2 Differentiation Test Increasingly Used in US
Number of HIV-2 diagnoses remains low; more false positives seen with greater use of differentiation test.
Discordance Between ART Prescribing Practices and Guidelines in Pregnant Women
Data published in JAMA Network Open suggest that prescribing practices for ART in pregnant women living with HIV in the US do not align optimally with national guidelines.
Herpes Simplex Virus Type 2 Contributes Considerably to HIV Acquisition
A substantial number of HIV infections are likely attributable to pre-existing infection with the herpes simplex virus type 2.
Early Antiretroviral Therapy May Not Achieve HIV Remission in Infants
Similar proportion of infants attain, sustain viral suppression when starting <48 hours, 2 to 14 days after birth.
Nurses Can Help Manage Drug Interactions in HIV/Hep C Treatment
Administration of simeprevir is more problematic with ART; sofosbuvir has fewest interactions with ART.
Antiretroviral Prescribing in Pregnancy Strays From National Guidelines
Many prescribed ARVs with insufficient evidence, not recommended for use in pregnant women with HIV.
Children With HIV May Benefit From Alendronate
Alendronate treatment is well-tolerated and improved bone mineral density (BMD) with no safety concerns in children and adolescents with perinatally acquired HIV.
TB Prevention Should Be Delayed Until After Pregnancy in HIV-Infected Women
Safety and efficacy of isoniazid for the prevention of tuberculosis may vary between HIV-infected pregnant and postpartum women.
Ethnic Disparities in Preexposure Prophylaxis Among Men Having Sex With Men
According to the United States Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report, preliminary data from 2017 show that gay, bisexual, and other men who have sex with men accounted for 67% of incident diagnoses of HIV.
Preventing HIV Infection in Men Who Have Sex with Men: A Clinical Review
Of the estimated 38,739 new cases of HIV reported in 2017, 70% were among men who have sex with men. Use of daily PrEP can virtually eliminate the risk of developing HIV, if used as prescribed.
Lower Education, Hepatitis C Co-Infection Linked to Earlier Menopause in HIV
In women with HIV, lower education and hepatitis C co-infection are independently associated with the onset of menopause before age 45 years.
Distribution of Self-Test Kits Can Up HIV Awareness
Distribution of HIV self-tests among men who have sex with men can increase testing and newly identified infections.
Test That Helps With HIV Treatment Selection Gets FDA Clearance
The test may help clinicians tailor HIV therapy for their patients.
Want to read more?
Please login or register first to view this content.
Next post in HIV/AIDS Information Center
